Related references
Note: Only part of the references are listed.STAT3 as a central mediator of neoplastic cellular transformation
David A. Frank
CANCER LETTERS (2007)
A small-molecule enhancer of signal transducer and activator of transcription 1 transcriptional activity accentuates the antiproliferative effects of IFN-γ in human cancer cells
Rebecca A. Lynch et al.
CANCER RESEARCH (2007)
Jak2: normal function and role in hematopoietic disorders
James N. Ihle et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2007)
Pyridone 6, a pan-janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells
Laura Pedranzini et al.
CANCER RESEARCH (2006)
Identification of human STAT5-dependent gene regulatory elements based on interspecies homology
Erik A. Nelson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma: Interplay of growth factors, their receptors and stromal interactions
Constantine S. Mitsiades et al.
EUROPEAN JOURNAL OF CANCER (2006)
Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor
JV Alvarez et al.
CANCER RESEARCH (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancer
EB Haura et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
Isolation of unique STAT5 targets by chromatin immunoprecipitation-based gene identification
EA Nelson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells
M Chatterjee et al.
BLOOD (2004)
A review of depsipeptide and other histone deacetylase inhibitors in clinical trials
R Piekarz et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein
JL Aron et al.
BLOOD (2003)
Histone deacetylase inhibitors in cancer treatment
DM Vigushin et al.
ANTI-CANCER DRUGS (2002)
Expression of IL-6 and IL-6 receptors by circulating clonotypic B cells in multiple myeloma: Potential for autocrine and paracrine networks
AJ Szczepek et al.
EXPERIMENTAL HEMATOLOGY (2001)
The Jak-STAT pathway
K Imada et al.
MOLECULAR IMMUNOLOGY (2000)
Share Paper
